Shares of Pharmaceutical Product Development PPDI are higher on the session by 0.39%, trading at $26.89.
Overall put volume is now running at 14.89x the daily average, with 100% of all puts traded being purchases on the offer. 2,010 contracts have traded on the session so far.
Pharmaceutical Product Development, Inc. is a global contract research organization providing drug discovery and development services. Its clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in